This information collection request
supports agency guidance regarding "Dear Healthcare Provider"
Letters. Respondents to the collection are manufacturers and
distributors of drugs for which such a letter is required under 21
CFR part 200.5. The burden reflects the estimated time associated
with the coordination and preparation of these letters with
respondents so that they may be issued accordingly. The letters
communicate new and important information about prescription drug
and biological products (drugs).
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.